LG unveils improved pathology AI model, EXAONE Path 2.0

LG AI Research, the artificial intelligence (AI) lab under South Korea's LG Group, said Wednesday it has unveiled its upgraded pathology AI model, EXAONE Path 2.0. Compared with the previous 1.0 version, EXAONE Path 2.0 delivers enhanced accuracy in analyzing and predicting genetic mutations, gene expression patterns and subtle structural changes in human cells and tissues, using pathological tissue images, according to LG AI Research. It noted that the model has been trained on over 10,000 datasets where whole slide images are paired with multiomics information, enabling it to predict gene activity solely through image analysis without the need for expensive genomic testing. "With EXAONE Path 2.0, genetic testing can be completed in under one minute, compared with the more than two weeks it used to take," Park Yong-min, a lead researcher at LG AI Research, said. "This will help secure the golden time for cancer patient treatment." He added that doctors and pharmaceutical companies can use EXAONE Path 2.0 to rapidly analyze cancer patients' pathological images, identify gene mutations anWeiter zum vollständigen Artikel bei Korea Times Weiter zum vollständigen Artikel bei Korea Times